Publications by authors named "Mary Boy"

Claim this Profile
R
Risk Factors for Major Adverse Cardiovascular Events in Phase III and Long-Term Extension Studies of Tofacitinib in Patients With Rheumatoid Arthritis.
Christina Charles-Schoeman, Ryan DeMasi, Hernan Valdez, Koshika Soma, Lie-Ju Hwang, Mary G Boy

Arthritis Rheumatol· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lymphoma in the Tofacitinib Rheumatoid Arthritis Clinical Development Program.
Xavier Mariette, Connie Chen, Pinaki Biswas, Kenneth Kwok, Mary G Boy

Arthritis Care Res (Hoboken)· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular safety findings in patients with rheumatoid arthritis treated with tofacitinib, an oral Janus kinase inhibitor.
Christina Charles-Schoeman, Pierre Wicker, Miguel A Gonzalez-Gay, Mary Boy, Andrea Zuckerman

Semin Arthritis Rheum· December 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of tofacitinib and other DMARDs on lipid profiles in rheumatoid arthritis: implications for the rheumatologist.
Christina Charles-Schoeman, Miguel A Gonzalez-Gay, Irina Kaplan, Mary Boy, Jamie Geier

Semin Arthritis Rheum· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review and meta-analysis of serious infections with tofacitinib and biologic disease-modifying antirheumatic drug treatment in rheumatoid arthritis clinical trials.
Vibeke Strand, Sima Ahadieh, Jonathan French, Jamie Geier, Sriram Krishnaswami, Mary Boy

Arthritis Res Ther· December 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety, tolerability, and pharmacokinetics of single oral doses of tofacitinib, a Janus kinase inhibitor, in healthy volunteers.
Sriram Krishnaswami, Mary Boy, Vincent Chow, Gary Chan

Clin Pharmacol Drug Dev· March 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Changes in serum creatinine in patients with active rheumatoid arthritis treated with tofacitinib: results from clinical trials.
John D Isaacs, Andrea Zuckerman, Sriram Krishnaswami, Chudy Nduaka, Shuping Lan, Mary G Boy

Arthritis Res Ther· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pharmacokinetics of tofacitinib, a janus kinase inhibitor, in patients with impaired renal function and end-stage renal disease.
Sriram Krishnaswami, Vincent Chow, Mary Boy, Cunshan Wang, Gary Chan

J Clin Pharmacol· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Double-blind, placebo-controlled, dose-escalation study to evaluate the pharmacologic effect of CP-690,550 in patients with psoriasis.
Mary G Boy, Cunshan Wang, Bethanie E Wilkinson, Vincent Fung-Sing Chow, Alan T Clucas

J Invest Dermatol· September 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis